-
Posted: September 30th, 2010, 8:00am CDT
Both male and female relatives of women diagnosed with breast cancer before the age of 35 are at an increased risk of other cancers even if they do not carry faulty BRCA1 and BRCA2 genes, scientists have discovered. The study*, published in the British Journal of Cancer** today (Wednesday) looked at the risks of breast and other cancers for the relatives of young women diagnosed with the disease...
-
Posted: September 30th, 2010, 8:00am CDT
New studies on breast cancer screening, treatment, genetics and survival were released in advance of the 2010 Breast Cancer Symposium. The symposium is being held October 1-3, 2010, at the Gaylord National Hotel in Suburban Washington, DC (National Harbor, Md.)...
-
Posted: September 30th, 2010, 6:00am CDT
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center...
-
Posted: September 30th, 2010, 6:00am CDT
Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer...
-
Posted: September 30th, 2010, 5:00am CDT
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers...
-
Posted: September 30th, 2010, 5:00am CDT
The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks, and options for treatment and prevention, surrounding breast cancer. According to the American Cancer Society more than 207,000 women nationwide will be diagnosed with the disease this year, with more than 6,800 new cases expected in New Jersey...
-
Posted: September 30th, 2010, 4:00am CDT
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy. The cognitive effects of chemotherapy, often referred to as "chemobrain," have been known for years...
-
Posted: September 30th, 2010, 2:00am CDT
A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute of Physics' journal Biomicrofluidics...
-
Posted: September 29th, 2010, 8:00am CDT
In early September the Medicines and Healthcare products Regulatory Agency (MHRA) announced encouraging preliminary results of the UK testing on the silicone gel breast implants manufactured by the French company PIP. The French medical device regulatory authority (AFSSAPS) has announced the results of their testing...
-
Posted: September 29th, 2010, 7:00am CDT
Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development...
-
Posted: September 29th, 2010, 7:00am CDT
Patients with triple-negative breast cancer, one of the hardest subtypes to treat, may have a unique biomarker that would enable them to receive more targeted therapy, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development...
-
Posted: September 29th, 2010, 7:00am CDT
Kaiser Health News: "A little-noticed section in the health-care overhaul aims to raise awareness among young women and their doctors about the risk of breast cancer between the ages of 15 and 44...
-
Posted: September 29th, 2010, 6:00am CDT
Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib. This is possible, the researchers from AVEO Pharmaceuticals, Inc. said, because they have used a new way of creating animal tumor models that mimic tumor variation seen in humans...
-
Posted: September 29th, 2010, 6:00am CDT
Women seeking appointments for breast biopsies at Harbor-UCLA Medical Center have reported facing wait times as long as five months, the Los Angeles Times reports. One Harbor-UCLA physician -- who asked not to be identified -- said the hospital's average wait time for breast biopsies is between eight and nine weeks...
-
Posted: September 29th, 2010, 6:00am CDT
Australian researchers have used sophisticated new protein screening technology to profile basal breast cancer, a particularly aggressive sub-type of breast cancer, identifying specific targets for future treatments. Basal breast cancers represent between 10 and 27% of all breast cancers, depending on the population sampled...
-
Posted: September 29th, 2010, 5:00am CDT
The federal health reform law (PL 111-148) includes a "little-noticed" provision that allocates $9 million annually for four years, starting in 2010, for programs to increase awareness about the risk of breast cancer in women ages 15 through 44, the Washington Post reports...
-
Posted: September 29th, 2010, 4:00am CDT
A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure®...
-
Posted: September 29th, 2010, 4:00am CDT
A year after a government panel revised its recommendations for breast cancer screening, many professional organizations have not followed suit. Where does this leave the average woman? "Experts agree mammography saves lives, and all major organizations still recommend regular mammograms...
-
Posted: September 29th, 2010, 3:00am CDT
A study, published in the October issue of the American Journal of Nursing (AJN), revealed that nearly 80% of men are unaware of their breast cancer risk despite having a family history of the disease. One hundred percent of respondents also reported that their healthcare provider did not discuss the disease with them...
-
Posted: September 28th, 2010, 7:00am CDT
The return of a delectable signature item to Panera Bread® bakery-café locations during the month of October will help New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center tackle a disease that affects one in eight U.S. women -- breast cancer...
-
Posted: September 28th, 2010, 3:00am CDT
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear in the online issue of Journal of Clinical Oncology...
-
Posted: September 27th, 2010, 3:00am CDT
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives...
-
Posted: September 27th, 2010, 2:00am CDT
Breast cancer incidence declined among postmenopausal women in Canada as their use of hormone therapy declined, according to a study published online September 23 in The Journal of the National Cancer Institute...
-
Posted: September 27th, 2010, 2:00am CDT
While increased research into some women's health issues, including breast and cervical cancer, has resulted in significant progress in the past 20 years, few gains have been made in other areas, such as reducing unintended pregnancy, according to a government-sponsored report released on Thursday, the Wall Street Journal reports...
-
Posted: September 26th, 2010, 2:00am CDT
New evidence found that routine activity during the day at work or home may be important for breast cancer prevention...
-
Posted: September 25th, 2010, 2:00pm CDT
Hologic's Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system has been recommended unanimously for approval by the Radiological Devices Panel of the FDA, at Gaithersburg, Maryland. Although the panel's recommendations are not binding, the FDA (Food and Drug Administration) usually goes along with their decision, especially if it was unanimous...
-
Posted: September 25th, 2010, 4:00am CDT
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced that the Radiological Devices Panel (Panel) of the U.S...
-
Posted: September 25th, 2010, 3:00am CDT
The International Journal of Hyperthermia is Marking Breast Cancer Awareness Month With a Timely Special Issue on the use of Hyperthermia as a Treatment for the Disease. The Journal's Publisher, Informa Healthcare, is Donating Money to Charity on Behalf of Every Free Article Download From the Special Issue...
-
Posted: September 24th, 2010, 6:00am CDT
David P. Winchester, MD, FACS, Medical Director, American College of Surgeons Cancer Programs and Chair, National Accreditation Program for Breast Centers, and Cary Kaufman, MD, FACS, Chair-Elect, National Accreditation Program for Breast Centers, are available to help reporters convey the importance of early detection and comprehensive treatment of breast cancer...
-
Posted: September 24th, 2010, 6:00am CDT
A new analysis finds that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that clinicians should address the mental health of cancer patients' loved ones...
-
Posted: September 24th, 2010, 6:00am CDT
The New York Times: "A new study suggests that increased awareness and improved treatments rather than mammograms are the main force in reducing the breast cancer death rate. ... The study, medical experts say, is the first to assess the benefit of mammography in the context of the modern era of breast cancer treatment...
-
Posted: September 24th, 2010, 3:00am CDT
Women who survive breast cancer often suffer from functional limitations that affect motion, strength and dexterity, which may adversely affect all-cause and competing-cause survival but not breast cancer survival, according to a study published online September 22 in The Journal of the National Cancer Institute...
-
Posted: September 23rd, 2010, 10:00am CDT
About 70% of women have sexual problems after breast cancer, researchers in Australia revealed in a new study published in the Journal of Sexual Medicine. Problems included libido, sexual satisfaction, concerns about body image which interfered with their sex drive, and menopausal symptoms linked to breast cancer treatments...
-
Posted: September 23rd, 2010, 6:00am CDT
A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70% of women were facing sexual function problems approximately two years post diagnosis...
-
Posted: September 23rd, 2010, 5:00am CDT
Women with early breast cancer who had some of their lymph nodes removed had the same survival rates as women who had a more aggressive surgery to remove all of their lymph nodes, according to new study published in the journal Lancet Oncology, the AP/Atlanta Journal-Constitution reports. The study is the largest trial to date to compare the two procedures...
-
Posted: September 23rd, 2010, 5:00am CDT
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, announced the start of clinical testing with SAR566658...
-
Posted: September 23rd, 2010, 4:00am CDT
Women confused about when to have a mammogram have a new interactive source of information - MammographySavesLives.org - launching this week along with a series of public service announcements on television and radio stations across the country...
-
Posted: September 22nd, 2010, 6:00pm CDT
Screening mammographies do not reduce the death rate from breast cancer as much as people had thought, especially among women aged 50 years or more, scientists in a large Norwegian study report in the New England Journal of Medicine (NEJM)...
-
Posted: September 22nd, 2010, 7:00am CDT
Celsion Corporation (Nasdaq: CLSN) announced today that an abstract on its Phase I/II DIGNITY trial of ThermoDox® in Recurrent Chest Wall (RCW) Breast Cancer has been accepted for a poster session at the 2010 Breast Cancer Symposium...
-
Posted: September 22nd, 2010, 4:00am CDT
Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been treated in a randomized Phase 2b study of the Company's CDX-011 (glembatumumab vedotin) antibody drug conjugate in glycoprotein NMB (GPNMB) expressing advanced, refractory breast cancer patients...
-
Posted: September 21st, 2010, 1:00pm CDT
An increasing number of women are undergoing mastectomy as a treatment for breast cancer or as a means of prevention. After breast cancer patients receive a mastectomy, a partial or full removal of the breast, often radiation therapy is required...
-
Posted: September 21st, 2010, 8:00am CDT
blue sky scrubs are making cancer patients feel good about themselves. Through Project Blue Sky, blue sky scrubs is able to provide patients with a fashion forward way to cover the most outward sign of sickness, hair loss. With every purchase, blue sky scrubs sends a free to hat to either a cancer patient at MD Anderson or the purchasing customer...
-
Posted: September 21st, 2010, 7:00am CDT
FDA has postponed a deadline for deciding whether to revoke approval of the drug Avastin for treatment of advanced breast cancer, the drug's manufacturer said on Friday, the New York Times' "Prescriptions" reports. The agency extended its review period until Dec. 17 because the manufacturer -- Roche unit Genentech -- submitted new data on Avastin, which works by blocking blood to tumors...
-
Posted: September 21st, 2010, 7:00am CDT
Mammography alone is not effective for breast cancer screening in women in their 40s because their breast tissue usually appears the same color as tumors in the images, according to a Stanford University study published recently in the Journal of the National Cancer Institute, Newsday/Chicago Tribune reports...
-
Posted: September 21st, 2010, 4:00am CDT
Casting for Recovery (CFR), a national, non-profit, support and educational program for women with breast cancer is pleased to announce a generous donation of $10,000 from Anthem Blue Cross and Blue Shield in Maine in support of local programs...
-
Posted: September 21st, 2010, 2:00am CDT
Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin® (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment...
-
Posted: September 20th, 2010, 5:00am CDT
To support October's Breast Cancer Awareness Month, the American Institute for Cancer Research (AICR) is now offering the AICR Breast Cancer Prevention Pack, one convenient packet of science-based materials to help women prevent breast cancer through basic lifestyle changes...
-
Posted: September 20th, 2010, 5:00am CDT
A new material could help surgeons more accurately locate breast cancers, reduce the need for second surgeries and minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of silica, a porous glass, can mark the location of early-stage tumors to show their position using ultrasound imaging in the operating room...
-
Posted: September 20th, 2010, 4:00am CDT
Boehringer Ingelheim announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer...
-
Posted: September 20th, 2010, 4:00am CDT
A large international team of researchers led by the Mayo Clinic in the US has discovered that some individuals whose risk of breast cancer may be increased by carrying a variant of the BRCA1 gene may also possess other gene variants that can modify that risk, bringing closer the day when it will be possible to determine individual risk for breast cancer in carriers of BRCA1...
-
Posted: September 20th, 2010, 3:00am CDT
Fat-derived stem cells can be safely used to aid reconstruction of breast tissue after mastectomy as long as there is no evidence of active cancer, according to researchers at the University of Pittsburgh School of Medicine. Their findings are available in Tissue Engineering Part A...
-
Posted: September 18th, 2010, 4:00am CDT
Cora Wallace was 37 when she discovered a lump in her right breast. She was newly divorced, raising two children, and was scared to death. Before she called her doctor, Wallace started researching breast cancer options on the internet. According to TMD Limited, a medical tourism company, over half of the 750,000 Americans who travel overseas for medical treatment find clinics through the web...
-
Posted: September 17th, 2010, 7:00am CDT
In the Life After Cancer Epidemiology (LACE) study, 1,897 participants diagnosed with early-stage breast cancer between 1997 and 2000 and recruited on average 2 years post-breast cancer diagnosis were evaluated for the association between alcohol intake and breast cancer recurrence and death. The women, who were generally light drinkers, were followed for an average of 7.4 years...
-
Posted: September 17th, 2010, 4:00am CDT
Testing is available to help identify if a woman is likely to face one of her gender's worst fears: inherited breast and ovarian cancer...
-
Posted: September 16th, 2010, 8:00am CDT
Chronic stress acts as a sort of fertilizer that feeds breast cancer progression, significantly accelerating the spread of disease in animal models, researchers at UCLA's Jonsson Comprehensive Cancer Center have found...
-
Posted: September 16th, 2010, 7:00am CDT
Moores UCSD Cancer Center at the University of California, San Diego has been designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR)...
-
Posted: September 16th, 2010, 4:00am CDT
57% of breast care nurses who took part in a UK survey for the charity Breast Cancer Care feel that there is inadequate provision for women with secondary breast cancer, a progressive incurable disease that kills half a million women worldwide every year after the cancer spreads to other organs...
-
Posted: September 15th, 2010, 9:00am CDT
New scientific research from the University of Southampton has revealed that a plant compound in watercress may have the ability to suppress breast cancer cell development by 'turning off' a signal in the body and thereby starving the growing tumour of essential blood and oxygen...
-
Posted: September 15th, 2010, 8:00am CDT
Scientists have discovered for the first time that studying calcium deposits in the breast, often detected through screening, could help doctors diagnose breast cancer more effectively. The study*, published in the British Journal of Cancer** today (Wednesday), examined the relationship between the composition of these deposits found in breast tissue and the malignancy of a tumour...
-
Posted: September 14th, 2010, 5:00am CDT
Physicians have long noticed that breast cancer patients who have had surgery or radiation therapy have an heightened risk of developing angiosarcoma, a rare type of cancer that originates in the lining of the blood vessels. Now, researchers at Loyola University Health System in Maywood, Ill., have focused in on a finding that could be a possible precursor to angiosarcoma...
-
Posted: September 11th, 2010, 3:00am CDT
AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection, replacing the previously approved monthly dose of 250mg, for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy...
-
Posted: September 8th, 2010, 5:00am CDT
Many women enduring hot flashes experience the heat, sweat and reddened upper body as an uncomfortable inconvenience. However, hot flashes can greatly diminish a woman's quality of life, disrupting sleep at night or causing embarrassment as she goes about her daily business. Hot flashes, called flushes in medical circles, occur commonly in women with a history of breast cancer...
-
Posted: September 8th, 2010, 4:00am CDT
Women at increased risk of breast and ovarian cancer because of inherited mutations of the BRCA1 or BRCA2 genes who had prophylactic mastectomy or salpingo-oophorectomy (removal of the fallopian tubes and ovaries) had an associated decreased risk of breast cancer and ovarian cancer, according to a study in the September 1 issue of JAMA...
-
Posted: September 8th, 2010, 3:00am CDT
A mathematical tool known as a Monte Carlo analysis could help improve the way X-rays are used for mammography and reduce the number of breast cancers missed by the technique as well as avoiding false positives, according to research published this month in the International Journal of Low Radiation...
-
Posted: September 7th, 2010, 6:00am CDT
Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90 per cent of metastatic breast carcinoma (MBC) patients. Correlations were observed with both the patients' monocyte (i.e...
-
Posted: September 6th, 2010, 5:00am CDT
The Medicines and Healthcare products Regulatory Agency (MHRA) has received encouraging results of UK testing on the silicone gel breast implants manufactured by the French company Poly Implant Prosthese (PIP). The tests found no evidence of genotoxicity (potential for cancer) or chemical toxicity of the filler material in the implants...
-
Posted: September 5th, 2010, 2:00am CDT
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment...
-
Posted: September 5th, 2010, 2:00am CDT
Recent studies have shown that acupuncture can help control a number of symptoms and side effects -- such as pain, fatigue, dry mouth, nausea, and vomiting -- associated with a variety of cancers and their treatments...
-
Posted: September 5th, 2010, 2:00am CDT
About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread...
-
Posted: September 4th, 2010, 2:00am CDT
New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells...
-
Posted: September 3rd, 2010, 10:00am CDT
Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell...
-
Posted: September 2nd, 2010, 7:00am CDT
A study published in the Journal of the American Medical Association suggests that women with a gene mutation linked to breast and ovarian cancer face lower risks of developing such cancer after receiving mastectomies or having their ovaries removed, The Wall Street Journal reports...
-
Posted: September 2nd, 2010, 6:00am CDT
Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training...
-
Posted: September 2nd, 2010, 5:00am CDT
Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer...
-
Posted: September 2nd, 2010, 5:00am CDT
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study...
-
Posted: September 2nd, 2010, 3:00am CDT
When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center. Where a woman goes for breast cancer treatment can vary widely - ranging from small private practices to large hospital settings...
-
Posted: September 2nd, 2010, 3:00am CDT
The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists, oncologists in private practice, third-party payers, and a patient advocate....
-
Posted: September 1st, 2010, 8:00am CDT
Eisai Inc. announced today that it has received notification from the U.S...
-
Posted: September 1st, 2010, 7:00am CDT
Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers. The implications - that a high-fat diet may have detrimental effects independent of its effect to cause obesity - could drive new cancer prevention efforts...
-
Posted: September 1st, 2010, 5:00am CDT
A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient...
-
Posted: September 1st, 2010, 3:00am CDT
Women with the inherited mutations of the BRCA1 or BRCA2 genes who had preventive (prophylactic) breast removal (mastectomy) or the removal of the fallopian tubes and ovaries (salpingo-oophorectomy) were found to have a significantly lower risk of developing ovarian and breast cancers, says a study published in JAMA (Journal of the American Medical Association), September 1st issue...